To address these challenges, we conducted a comprehensive project that combined industry research, expert interviews, and data analysis to deliver detailed insights on each key digital health solution provider.

1. Market and Customer Analysis: We conducted a market analysis of the digital health landscape, identifying key players offering solutions tailored to pharma, such as digital therapeutics, patient adherence platforms, and real-world evidence (RWE) data collection tools. This included a breakdown of each provider’s core competencies, such as Bright Insight’s focus on IoT for connected devices and Click Therapeutics’ strength in digital therapeutics.

2. Expert Interviews with Pharma Customers: To gather authentic customer perspectives, we connected with senior leaders in pharma companies (e.g., heads of digital health or innovation) who had direct experience with these providers. They shared insights on use cases, key selection criteria, challenges with implementation, and overall satisfaction with the solutions.

3. Key Criteria Analysis: We identified and ranked selection criteria that pharma companies prioritize when choosing a digital health provider, such as regulatory compliance (e.g., FDA, GDPR), integration capabilities with existing pharma systems, scalability, and ROI. This analysis helped pinpoint the providers best suited for long-term partnerships in a highly regulated industry.

4. Solution Mapping and Recommendations: Based on the findings, we created a solution map, categorizing providers by their core strengths and specific applications in the pharma value chain (e.g., patient engagement, real-world data analytics, digital therapeutics). We then provided strategic recommendations to the investment firm on which providers showed the most promise for growth and scalability in the pharma industry.